Abiopharma

🔍 Leabman Michael Aaron (Executive)

Company: Movano Inc. (MOVE)

Report Date: 2026-01-05

Detailed Transactions and Holdings:

• Acquired 42,250 shares of Common Stock at $1.25 per share (Direct)
  Date: 2026-01-06 | Code: M | equity_swap_involved: false | shares_owned_after: 42,606.00 | transaction_form_type: 4
• Sold 3,293 shares of Common Stock at $7.34 per share (Direct)
  Date: 2026-01-07 | Code: S | equity_swap_involved: false | shares_owned_after: 39,313.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 3,593 shares of Common Stock at $7.26 per share (Direct)
  Date: 2026-01-08 | Code: S | equity_swap_involved: false | shares_owned_after: 35,720.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 783 shares of Common Stock at $7.27 per share (Direct)
  Date: 2026-01-09 | Code: S | equity_swap_involved: false | shares_owned_after: 34,937.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 42,250 shares of Stock Options (Right to Buy) at $1.25 per share (Derivative)
  Date: 2026-01-06 | Code: M | Expires: 2026-03-15 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F5

Footnotes:

• F1: Represents shares sold to pay withholding taxes and exercise prices due in connection with the exercise of stock option awards granted to the reporting person in lieu of cash salary during 2025.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.11 to $7.68, inclusive. The reporting person undertakes to provide to Movano Inc., any security holder of Movano Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.14 to $7.49, inclusive. The reporting person undertakes to provide to Movano Inc., any security holder of Movano Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.16 to $7.46, inclusive. The reporting person undertakes to provide to Movano Inc., any security holder of Movano Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F5: This option award was granted contingent upon shareholder approval of an amendment to the Omnibus Incentive Plan that increases the number of shares of Common Stock authorized for issuance under the Plan (the "Plan Amendment"). The option became exerciseable upon shareholder approval of the Plan Amendment on December 16, 2025.